emerging use of bpc 157 BPC-157: What It Is, What We Know, and Why Its for Arthritis Remains Unproven BPC-157 FDA Approval Status: Is

Journal of Endocrinology and Metabolism, 4(1-2), 87-95

In short: animals given BPC-157 heal Achilles tendons, muscle tears, ligament injuries, and even crushed bones dramatically faster and stronger than untreated animals

In the future, with increased scientific research investment, its application scenarios will be further expanded

In this context, the interregnum compels us to reimagine the role of planning in the face of systemic crises

TRIS-BPC157 was applied intramuscularly (i.m.) either at the 7 th , 9 th , 14 th and 16 th post-operative day (10 g/kg b.w.) or once daily in the period of the 7 th -21 st post-operative days (10 g or 10 ng/kg b.w.)

Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era